HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid].

Abstract
A 76 year old patient with actinic reticuloid was treated with Cyclosporin A. 11 months after beginning the immunosuppressive therapy, he developed lymphoedema and livid nodular skin lesions of the right leg, which histologically showed Kaposi's sarcoma. After stopping the Cyclosporin A and intralesional therapy with Interferon alpha, no regression of the Kaposi sarcoma could be seen. The characteristics of Kaposi sarcoma arising during immunosuppressive therapy and the differences in incidence, risk groups and distribution pattern compared to the classic sporadic and the AIDS-related Kaposi sarcoma will be described. The development of Kaposi sarcoma during immunosuppressive therapy for actinic reticuloid has not been previously described.
AuthorsV Waldmann, W Kempf, G Burg, R Dummer
JournalDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete (Hautarzt) Vol. 48 Issue 4 Pg. 262-5 (Apr 1997) ISSN: 0017-8470 [Print] Germany
Vernacular TitleKaposi-Sarkom unter Cyclosporin-A-Therapie bei aktinischem Retikuloid.
PMID9206716 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Cyclosporine
Topics
  • Aged
  • Cell Transformation, Neoplastic (chemically induced, pathology)
  • Cyclosporine (adverse effects, therapeutic use)
  • Humans
  • Immunosuppressive Agents (adverse effects, therapeutic use)
  • Male
  • Photosensitivity Disorders (drug therapy, pathology)
  • Risk Factors
  • Sarcoma, Kaposi (chemically induced, pathology)
  • Skin (pathology)
  • Skin Neoplasms (chemically induced, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: